Trillium Therapeutics Stock Price

0.00 (0.0%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Trillium Therapeutics Inc TRIL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 10.66 04:33:39
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
10.52 11.67 1.15 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 10.66 USD

Trillium Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 945.38M 88.68M 12.35M $ 126.57k $ - -2.26 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Trillium Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TRIL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week12.2212.4810.5611.271,736,900-1.56-12.77%
1 Month12.7014.9310.5612.501,455,545-2.04-16.06%
3 Months11.8015.922610.5612.891,722,400-1.14-9.66%
6 Months10.1920.968.5413.982,141,5650.474.61%
1 Year6.3520.962.5010.281,990,4964.3167.87%
3 Years7.2020.960.24056.611,256,4353.4648.06%
5 Years7.2520.960.24056.70796,4163.4147.03%

Trillium Therapeutics Description

Trillium Therapeutics Inc is a Canadian clinical stage immuno-oncology company which is engaged in developing therapies for the treatment of cancer. The lead program of the company is TTI-621 which is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory signal. The company has proprietary medicinal chemistry platform, using fluorine chemistry which permits the creation of new chemical entities with pharmacological properties. The company operates through the single segment being Research and development of therapies for the treatment of cancer.

Your Recent History
Trillium T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.